P1,P4-Di(uridine-5′-tetraphosphate) Typical Properties
Diquafosol Tetrasoudium or P1,P4-Di(Uridine-5′-Tetraphosphate);INS 365;D03864;Diquafosol sodium;Diquafosol sodium (jan);Diquafosol tetrasodium;Diquafosol tetrasodium (usan);Diquafosol Impurity 7(UP4U)
Diquafoxol tetrasodium works by activating the P2Y2 receptor in the conjunctiva and promoting the secretion of water and mucin components in tear fluid, thereby improving the quality and quantity of tear fluid.
Diquafosol tetrasodium eye drops are the first P2Y2 receptor agonist eye drops approved for marketing in the world. They treat dry eye with a new mechanism of action: improve the symptoms of dry eye by promoting the secretion of water and mucin, and bring the tear film closer normal status. In clinical studies in Japan, no serious ocular and systemic adverse reactions were found. Diquas is well tolerated, so it can be used for long-term treatment of dry eye symptoms
P1,P4-Di(uridine-5′-tetraphosphate) Packaging and Shipping
1kg/bottle or bag
25kgs/drum or bag
Shipping: Shipped in 1-3 days after payment